1 | 1299379 | Increased deoxycytidine kinase activity in cancer cells and inhibition by difluorodeoxycytidine. | Oncol Res | 1992 |
1 |
2 | 1406603 | Nucleotide specificity of human deoxycytidine kinase. | Mol Pharmacol | 1992 Sep |
1 |
3 | 1601333 | Deoxycytidine protects normal bone marrow progenitors against Ara-C and gemcitabine cytotoxicity without compromising their activity against cisplatin-resistant human ovarian cancer cells. | Gynecol Oncol | 1992 Apr |
2 |
4 | 7481843 | Induction of resistance to 2',2'-difluorodeoxycytidine in the human ovarian cancer cell line A2780. | Semin Oncol | 1995 Aug |
1 |
5 | 7481845 | Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors. | Semin Oncol | 1995 Aug |
1 |
6 | 7980770 | New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase. | Pharm World Sci | 1994 Apr 15 |
1 |
7 | 7986250 | General pharmacology of gemcitabine hydrochloride in animals. | Arzneimittelforschung | 1994 Sep |
1 |
8 | 8186164 | Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study. | Ann Oncol | 1994 Feb |
2 |
9 | 8278936 | Developmental toxicity of gemcitabine, an antimetabolite oncolytic, administered during gestation to CD-1 mice. | Teratology | 1993 Oct |
1 |
10 | 8356916 | Regulation of deoxycytidine kinase activity and inhibition by DFDC. | Adv Enzyme Regul | 1993 |
3 |
11 | 8364254 | Effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on wild type and variant mouse leukemia L1210 cells. | Oncol Res | 1993 |
2 |
12 | 8494545 | Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase. | Biochem Pharmacol | 1993 May 5 |
8 |
13 | 8551802 | Comparison of the induction of apoptosis in human leukemic cell lines by 2',2'-difluorodeoxycytidine (gemcitabine) and cytosine arabinoside. | Leuk Res | 1995 Nov |
2 |
14 | 8651941 | Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidine. | Biochem Pharmacol | 1996 Apr 12 |
3 |
15 | 8688318 | Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy. | Br J Cancer | 1996 Jul |
4 |
16 | 8713072 | Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cells. | Biochem J | 1996 Jul 15 |
1 |
17 | 8724701 | 2',2'-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA). | Stem Cells | 1996 May |
3 |
18 | 8862446 | Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine. | Exp Hematol | 1996 Sep |
3 |
19 | 8893888 | An estimate of the cost effectiveness of gemcitabine in stage IV non-small cell lung cancer. | Semin Oncol | 1996 Oct |
1 |
20 | 9079672 | Cloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2. | J Biol Chem | 1997 Mar 28 |
1 |
21 | 9194475 | Combination chemotherapy studies with gemcitabine. | Semin Oncol | 1997 Apr |
1 |
22 | 9463485 | Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs. | Mol Pharmacol | 1998 Feb |
1 |
23 | 9523737 | Gemcitabine induces programmed cell death and activates protein kinase C in BG-1 human ovarian cancer cells. | Cancer Chemother Pharmacol | 1998 |
4 |
24 | 9551690 | Antitumor effect of the nucleoside analogs 2-chlorodeoxyadenosine and 2',2'-difluorodeoxycytidine on human hepatoma HepG2 cells. | J Hepatol | 1998 Mar |
1 |
25 | 9592200 | The efficacy of 2',2'-difluorodeoxycytidine (gemcitabine) combined with interferon in human renal cell carcinoma cell lines. | Int J Oncol | 1998 Jun |
5 |
26 | 9592201 | The efficacy of 2',2'-difluorodeoxycytidine (gemcitabine) and vinblastine combined with interferon in nude mice xenografts of human renal cell carcinoma. | Int J Oncol | 1998 Jun |
5 |
27 | 9598122 | Similar changes were induced by Cladribine and by gemcitabine, in the deoxypyrimidine salvage, during short-term treatments. | Adv Exp Med Biol | 1998 |
1 |
28 | 9598134 | Increased sensitivity to gemcitabine of P-gP and MRP overexpressing human non-small cell lung cancer cell lines. | Adv Exp Med Biol | 1998 |
2 |
29 | 9598147 | Role of deoxycytidine kinase (dCK), thymidine kinase 2 (TK2), and deoxycytidine deaminase (dCDA) in the antitumor activity of gemcitabine (dFdC). | Adv Exp Med Biol | 1998 |
6 |
30 | 9613709 | Interactions of 2',2'-diflurodeoxycytidine (gemcitabine) with tumor necrosis factor alpha or its mutein VI in murine leukemias L1210 and P388. | Arch Immunol Ther Exp (Warsz) | 1998 |
2 |
31 | 9728590 | Evaluation of new drugs in small cell lung cancer: the activity of gemcitabine. | Semin Oncol | 1998 Aug |
1 |
32 | 9735415 | Bcl-2 overexpression is associated with resistance to paclitaxel, but not gemcitabine, in multiple myeloma cells. | Int J Oncol | 1998 Oct |
1 |
33 | 9739439 | Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors. | Ann Oncol | 1998 Jul |
1 |
34 | 9771951 | Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells. | Cancer Chemother Pharmacol | 1998 |
1 |
35 | 9772293 | Cell cycle arrest in ovarian cancer cell lines does not depend on p53 status upon treatment with cytostatic drugs. | Int J Oncol | 1998 Nov |
1 |
36 | 9776315 | Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase. | Biochem Pharmacol | 1998 Oct 15 |
4 |
37 | 9789222 | Economic evaluation of gemcitabine single agent therapy compared with standard treatment in stage IIIB and IV non-small cell lung cancer. | Med Oncol | 1998 Jul |
3 |
38 | 9845378 | Lack of cross-resistance with gemcitabine and cytarabine in cladribine-resistant HL60 cells with elevated 5'-nucleotidase activity. | Exp Hematol | 1998 Dec |
4 |
39 | 9858945 | 2'-2'-difluorodeoxycytidine: in vitro effects on cell-mediated immune response. | Anticancer Res | 1998 Sep-Oct |
2 |
40 | 9933028 | Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase. | Biochem Pharmacol | 1999 Feb 15 |
1 |
41 | 9933029 | Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines. | Biochem Pharmacol | 1999 Feb 15 |
9 |
42 | 9988115 | Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone. | Eur J Pharmacol | 1999 Jan 22 |
2 |
43 | 10063971 | The effects of gemcitabine and TPA on PKC signaling in BG-1 human ovarian cancer cells. | Oncol Res | 1998 |
6 |
44 | 10071592 | Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388. | Cancer Invest | 1999 |
1 |
45 | 10340887 | Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content. | Ann Surg Oncol | 1999 Apr-May |
7 |
46 | 10341297 | Induction of growth inhibition and apoptosis in pancreatic cancer cells by auristatin-PE and gemcitabine. | Int J Mol Med | 1999 Jun |
2 |
47 | 10388042 | Gemcitabine: Future Prospects of Single-Agent and Combination Studies. | Oncologist | 1997 |
1 |
48 | 10403525 | Inhibition of protein kinase C activator-mediated induction of p21CIP1 and p27KIP1 by deoxycytidine analogs in human leukemia cells: relationship to apoptosis and differentiation. | Biochem Pharmacol | 1999 Jul 1 |
2 |
49 | 10462544 | Phosphorylation of deoxycytidine analog monophosphates by UMP-CMP kinase: molecular characterization of the human enzyme. | Mol Pharmacol | 1999 Sep |
1 |
50 | 10477451 | In vitro study of the combination gemcitabine + fludarabine on freshly isolated chronic lymphocytic leukemia cells. | Haematologica | 1999 Sep |
1 |